NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank80
3Y CAGR-30.1%
Studio
Year-over-Year Change

Year-over-year net income growth rate

3Y CAGR
-30.1%/yr
Annual compound
Percentile
P80
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
202515.64%
2024-36.54%
2023-681.73%
202245.83%
2021-494.98%
20200.00%